• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥曲肽和酮咯酸治疗胆汁引流量增加的成功试验:一例报告

Successful Trial of Octreotide and Ketorolac for the Management of Increased Biliary Drain Output: A Case Report.

作者信息

Tiruneh Fasil, Awan Ahmad, Musa Abdullahi, Chen Daniel

机构信息

Department of Internal Medicine, Howard University Hospital.

Internal Medicine, Washington Dc Va Medical Center.

出版信息

Cureus. 2017 Jul 3;9(7):e1421. doi: 10.7759/cureus.1421.

DOI:10.7759/cureus.1421
PMID:28875094
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5580974/
Abstract

We describe a 69-year-old male patient with the status of obstructive jaundice post percutaneous biliary drainage for prior obstructive jaundice and who presented with a complaint of generalized weakness and increased output from the drainage tube. The patient developed worsening jaundice, which was noted to be obstructive in nature with a marked dilatation of the biliary tree and a distal obstruction of the common bile duct. Subsequently, a percutaneous biliary drain was placed for symptomatic management. However, the patient continued to have increased output from the drain, approximating 3-4 liters a day, which made the patient dependent on continuous intravenous hydration. The case presented a therapeutic challenge in reducing the drainage amount. We have tried a successful approach based on the physiologic effect of octreotide and nonsteroidal anti-inflammatory drugs (NSAIDs) in the formation of bile secretion. This approach has not been clearly described in the literature. We highlight the importance of further study to validate the use of these medications in similar clinical scenarios.

摘要

我们描述了一名69岁男性患者,既往因梗阻性黄疸行经皮胆道引流术,此次因全身乏力及引流管引流量增加前来就诊。患者黄疸加重,经检查为梗阻性黄疸,伴有胆管树明显扩张及胆总管远端梗阻。随后,为进行症状管理置入了经皮胆道引流管。然而,患者引流管引流量持续增加,每天约3 - 4升,这使得患者依赖持续静脉补液。该病例在减少引流量方面面临治疗挑战。我们基于奥曲肽和非甾体抗炎药(NSAIDs)对胆汁分泌形成的生理作用尝试了一种成功的方法。文献中尚未明确描述过这种方法。我们强调进一步研究以验证这些药物在类似临床情况中的应用的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e18/5580974/f847cbfaef46/cureus-0009-00000001421-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e18/5580974/4f49f7d53e52/cureus-0009-00000001421-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e18/5580974/1d85c9e9168f/cureus-0009-00000001421-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e18/5580974/683bef5e3763/cureus-0009-00000001421-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e18/5580974/6897200932a7/cureus-0009-00000001421-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e18/5580974/f847cbfaef46/cureus-0009-00000001421-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e18/5580974/4f49f7d53e52/cureus-0009-00000001421-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e18/5580974/1d85c9e9168f/cureus-0009-00000001421-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e18/5580974/683bef5e3763/cureus-0009-00000001421-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e18/5580974/6897200932a7/cureus-0009-00000001421-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e18/5580974/f847cbfaef46/cureus-0009-00000001421-i05.jpg

相似文献

1
Successful Trial of Octreotide and Ketorolac for the Management of Increased Biliary Drain Output: A Case Report.奥曲肽和酮咯酸治疗胆汁引流量增加的成功试验:一例报告
Cureus. 2017 Jul 3;9(7):e1421. doi: 10.7759/cureus.1421.
2
Acute kidney injury due to high-output external biliary drainage in a patient with malignant obstructive jaundice: a case report.恶性梗阻性黄疸患者因高流量体外胆汁引流导致急性肾损伤:一例病例报告
J Med Case Rep. 2019 Aug 13;13(1):251. doi: 10.1186/s13256-019-2195-4.
3
A possible role for ketorolac in the management of increased biliary drain output.酮咯酸在管理胆汁引流增加方面的可能作用。
Clin Res Hepatol Gastroenterol. 2023 May;47(6):102128. doi: 10.1016/j.clinre.2023.102128. Epub 2023 Apr 23.
4
Biliary leaks after laparoscopic cholecystectomy: time to stent or time to drain.腹腔镜胆囊切除术后胆漏:支架置入时机还是引流时机。
Hepatobiliary Pancreat Dis Int. 2008 Dec;7(6):628-32.
5
Endoscopic nasobiliary drain placement facilitates subsequent percutaneous transhepatic cholangiography.
Gastrointest Endosc. 1999 Feb;49(2):240-2. doi: 10.1016/s0016-5107(99)70493-1.
6
Role of preoperative biliary drainage in jaundiced patients who are candidates for pancreatoduodenectomy or hepatic resection: highlights and drawbacks.术前胆道引流在黄疸患者胰十二指肠切除术或肝切除术适应证中的作用:要点和缺点。
Ann Surg. 2013 Feb;257(2):191-204. doi: 10.1097/SLA.0b013e31826f4b0e.
7
Management of a patient with hepatic-thoracic-pelvic and omental hydatid cysts and post-operative bilio-cutaneous fistula: a case report.肝-胸-盆腔及网膜包虫囊肿合并术后胆皮瘘患者的管理:一例报告
Hepatogastroenterology. 1999 Jul-Aug;46(28):2202-7.
8
Comparison of efficacy and complications of endoscopic and percutaneous biliary drainage in malignant obstructive jaundice: a systematic review and meta-analysis.内镜下与经皮经肝胆道引流治疗恶性梗阻性黄疸的疗效及并发症比较:一项系统评价与Meta分析
Cancer Imaging. 2017 Oct 16;17(1):27. doi: 10.1186/s40644-017-0129-1.
9
EUS-guided transduodenal biliary drainage in unresectable pancreatic cancer with obstructive jaundice.内镜超声引导下经十二指肠胆管引流术治疗不可切除的胰腺癌合并梗阻性黄疸
JOP. 2007 Jul 9;8(4):438-43.
10
Clinical outcome of biliary drainage for obstructive jaundice caused by colorectal and gastric cancers.结直肠癌和胃癌所致梗阻性黄疸的胆道引流临床疗效。
Jpn J Clin Oncol. 2012 Dec;42(12):1161-7. doi: 10.1093/jjco/hys168. Epub 2012 Oct 16.

引用本文的文献

1
Acute kidney injury due to high-output external biliary drainage in a patient with malignant obstructive jaundice: a case report.恶性梗阻性黄疸患者因高流量体外胆汁引流导致急性肾损伤:一例病例报告
J Med Case Rep. 2019 Aug 13;13(1):251. doi: 10.1186/s13256-019-2195-4.

本文引用的文献

1
Meta-analysis of randomized clinical trials on safety and efficacy of biliary drainage before surgery for obstructive jaundice.手术前胆道引流术治疗梗阻性黄疸安全性和疗效的随机临床试验的荟萃分析。
Br J Surg. 2013 Nov;100(12):1589-96. doi: 10.1002/bjs.9260.
2
Above-Label Doses of Octreotide-LAR in Patients With Metastatic Small Intestinal Carcinoid Tumors.奥曲肽长效注射剂超量给药用于转移性小肠类癌肿瘤患者
Gastrointest Cancer Res. 2013 May;6(3):81-5.
3
Physiology of bile secretion.胆汁分泌的生理学
World J Gastroenterol. 2008 Oct 7;14(37):5641-9. doi: 10.3748/wjg.14.5641.
4
Dopaminergic inhibition of secretin-stimulated choleresis by increased PKC-gamma expression and decrease of PKA activity.多巴胺能通过增加蛋白激酶C-γ(PKC-γ)表达和降低蛋白激酶A(PKA)活性来抑制促胰液素刺激的胆汁分泌。
Am J Physiol Gastrointest Liver Physiol. 2003 Apr;284(4):G683-94. doi: 10.1152/ajpgi.00302.2002. Epub 2002 Dec 27.
5
Regulation of cholangiocyte bile secretion.胆管细胞胆汁分泌的调节。
J Hepatol. 1999 Jul;31(1):179-91. doi: 10.1016/s0168-8278(99)80180-9.
6
Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome.长效醋酸奥曲肽制剂与开放标签皮下注射醋酸奥曲肽治疗恶性类癌综合征的对比
J Clin Oncol. 1999 Feb;17(2):600-6. doi: 10.1200/JCO.1999.17.2.600.
7
Direct regulation of bile secretion by prostaglandins in perfused rat liver.前列腺素对灌注大鼠肝脏胆汁分泌的直接调节作用。
Hepatology. 1994 May;19(5):1208-13.
8
Management of biliary obstruction in patients with unresectable carcinoma of the pancreas.不可切除胰腺癌患者胆管梗阻的管理
Ann Surg. 1989 Mar;209(3):284-8. doi: 10.1097/00000658-198903000-00006.
9
Vasoactive intestinal peptide and secretin: effects of combined and separate intravenous infusions on bile secretion in man.血管活性肠肽与促胰液素:联合及单独静脉输注对人体胆汁分泌的影响
Scand J Gastroenterol. 1991 Jan;26(1):109-18. doi: 10.3109/00365529108996491.